Cervical dysplasia refers to abnormal changes in the cells lining the cervix, the lower part of the uterus that connects to the vagina. These changes are often detected through Pap smears or HPV tests and can range from mild to severe. Mild cervical dysplasia may resolve on its own, while more severe cases might progress to cervical cancer if left untreated. The primary cause of cervical dysplasia is persistent infection with high-risk strains of human papillomavirus (HPV). Other risk factors include a weakened immune system, early onset of sexual activity, multiple sexual partners, and cigarette smoking. Regular cervical screenings are crucial for early detection and management of cervical dysplasia. Treatment options vary based on the severity of dysplasia and may include close monitoring, procedures to remove or destroy abnormal cells, or, in extreme cases, surgical interventions. It is important for individuals diagnosed with cervical dysplasia to follow their healthcare provider's recommendations for appropriate follow-up and treatment to prevent potential progression to cervical cancer. Regular vaccination against HPV can also contribute to preventing cervical dysplasia.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia